• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成和评价构象受限的肽类似物作为Src SH3 结构域结合配体。

Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.

机构信息

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 41 Lower College Road, Kingston, RI 02881, USA.

出版信息

Biochimie. 2010 Sep;92(9):1153-63. doi: 10.1016/j.biochi.2010.01.017. Epub 2010 Jan 28.

DOI:10.1016/j.biochi.2010.01.017
PMID:20109515
Abstract

Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.

摘要

Src 激酶活性受 SH3 结构域与富含脯氨酸残基的蛋白质序列相互作用的调节。鉴定能够调节 Src 激酶活性的更有效的 SH3 结构域结合配体是一个主要研究课题。以前曾使用构象受限的肽来提高 Src SH2 结构域结合肽配体和 Src 底物结合位点肽底物的结合效力。通过在 N 端到 C 端 [VSLARRPLPPLP] 或 N 端到侧链侧翼残基之间环化来合成 Ac-VSLARRPLPPLP(1,Ac-VSL12,Kd=0.34 microM)的一系列肽类似物,以改善对 Src SH3 结构域的结合亲和力。与 1 相比,通过 N 端到 C 端 [VSLARRPLPPLP] 或 N 端到侧链侧翼残基之间环化合成的肽 [(β)AVS]LARRPLPPLP 和 [VSLE]RRPLPPLP 的结合亲和力至少低 6.4 倍(Kd=2.19-4.85 microM)。数据表明,与 N 端环化的 C 端或侧翼残基相比,核心 RPLPPLP 中的氨基酸的相互作用与 Src SH3 结构域内的残基显著减少。通过 C 端到丝氨酸侧链环化合成构象受限的肽 V[SLARRPLPPLP](5),与 1 相比,对 Src SH3 结构域的结合亲和力相当(Kd=0.35 microM)。因此,该模板可用于优化和生成更有效的类似物,提高稳定性。

相似文献

1
Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.合成和评价构象受限的肽类似物作为Src SH3 结构域结合配体。
Biochimie. 2010 Sep;92(9):1153-63. doi: 10.1016/j.biochi.2010.01.017. Epub 2010 Jan 28.
2
Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.作为Src SH2结构域结合抑制剂的pTyr-Glu-Glu-Ile的构象受限肽类似物。
J Med Chem. 2004 Jun 3;47(12):3131-41. doi: 10.1021/jm040008+.
3
Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.与设计的高亲和力肽配体复合的abl-SH3结构域的晶体结构:对SH3-配体相互作用的启示
J Mol Biol. 1998 Aug 21;281(3):513-21. doi: 10.1006/jmbi.1998.1932.
4
Identification and specificity studies of small-molecule ligands for SH3 protein domains.SH3蛋白结构域小分子配体的鉴定与特异性研究
J Med Chem. 2004 Oct 21;47(22):5405-17. doi: 10.1021/jm049533z.
5
Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.髓鞘碱性蛋白富含脯氨酸区域与SH3结构域的结合:配体构象及翻译后修饰效应的光谱学、微阵列和建模研究
Biochemistry. 2008 Jan 8;47(1):267-82. doi: 10.1021/bi701336n. Epub 2007 Dec 8.
6
The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.衔接蛋白Grb2的C末端SH3结构域与Gab1和SLP-76中缺乏SH3典型的P-x-x-P核心基序的序列具有高亲和力结合。
Oncogene. 2001 Mar 1;20(9):1052-62. doi: 10.1038/sj.onc.1204202.
7
Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.利用同源建模、分子动力学和分子场分析预测人发动蛋白-1 SH3结构域与其肽配体之间的结合亲和力。
J Proteome Res. 2006 Jan;5(1):32-43. doi: 10.1021/pr0502267.
8
SH3 domains and drug design: ligands, structure, and biological function.SH3结构域与药物设计:配体、结构及生物学功能
Biopolymers. 1997;43(5):383-400. doi: 10.1002/(SICI)1097-0282(1997)43:5<383::AID-BIP4>3.0.CO;2-R.
9
Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.使用不同波长荧光偏振探针同时检测Src SH3和SH2结构域结合情况。
Anal Biochem. 1999 Nov 1;275(1):62-73. doi: 10.1006/abio.1999.4305.
10
Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.采用基于α-甲基苯丙氨酰基的磷酸酪氨酸模拟物设计与合成构象受限的Grb2 SH2结构域结合肽
J Med Chem. 2005 Feb 10;48(3):764-72. doi: 10.1021/jm0492709.

引用本文的文献

1
A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.一种 PDK-1 别构激动剂可中和神经元细胞中胰岛素信号转导紊乱和β淀粉样肽毒性,并在体外发挥作用。
PLoS One. 2022 Jan 21;17(1):e0261696. doi: 10.1371/journal.pone.0261696. eCollection 2022.
2
Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling.环状肽作为蛋白激酶抑制剂:结构-活性关系和分子建模。
J Chem Inf Model. 2021 Jun 28;61(6):3015-3026. doi: 10.1021/acs.jcim.1c00320. Epub 2021 May 17.
3
Targeting kinase signaling pathways with constrained peptide scaffolds.
用受限肽支架靶向激酶信号通路。
Pharmacol Ther. 2017 May;173:159-170. doi: 10.1016/j.pharmthera.2017.02.014. Epub 2017 Feb 7.
4
Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors.达沙替尼-氨基酸和达沙替尼-脂肪酸缀合物作为蛋白酪氨酸激酶抑制剂的设计、合成及评价
ChemMedChem. 2017 Jan 5;12(1):86-99. doi: 10.1002/cmdc.201600387. Epub 2016 Dec 5.
5
4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities.4-芳基-4H-萘并吡喃衍生物的一锅法合成及对Src 激酶抑制和抗增殖活性的评价。
Daru. 2012 Dec 26;20(1):100. doi: 10.1186/2008-2231-20-100.